Jefferies analyst Tycho Peterson maintains $Bruker Corp (BRKR.US)$ with a buy rating, and maintains the target price at $85.
According to TipRanks data, the analyst has a success rate of 55.4% and a total average return of 7.4% over the past year.
Furthermore, according to the comprehensive report, the opinions of $Bruker Corp (BRKR.US)$'s main analysts recently are as follows:
Post the Q3 report, Bruker experienced continued softness in China and within the biopharma sector.
The company encountered a challenging earnings report amidst a difficult macroeconomic climate. Estimates are being adjusted to align with the reduced fiscal 2024 targets; however, the confidence remains that the company is strategically positioned in multi-omics and materials sciences, which should gain from the eventual upturn in biopharmaceutical demand and Chinese market conditions.
Bruker's third-quarter outcomes fell short of expectations, and the company has reduced its organic sales growth forecast for fiscal 2024. This revision was attributed to a sluggish recovery in China and emerging biopharma sectors. The adjustment to the guidance reflects previous projections that were perhaps too optimistic, rather than a significant decline in market conditions during the third quarter. Nevertheless, management has conveyed a confident outlook for 2025.
Note:
TipRanks, an independent third party, provides analysis data from financial analysts and calculates the Average Returns and Success Rates of the analysts' recommendations. The information presented is not an investment recommendation and is intended for informational purposes only.
Success rate is the number of the analyst's successful ratings, divided by his/her total number of ratings over the past year. A successful rating is one based on if TipRanks' virtual portfolio earned a positive return from the stock. Total average return is the average rate of return that the TipRanks' virtual portfolio has earned over the past year. These portfolios are established based on the analyst's preliminary rating and are adjusted according to the changes in the rating.
TipRanks provides a ranking of each analyst up to 5 stars, which is representative of all recommendations from the analyst. An analyst's past performance is evaluated on a scale of 1 to 5 stars, with more stars indicating better performance. The star level is determined by his/her total success rate and average return.
富瑞集團分析師Tycho Peterson維持$布魯克 (BRKR.US)$買入評級，維持目標價85美元。
根據TipRanks數據顯示，該分析師近一年總勝率為55.4%，總平均回報率為7.4%。
此外，綜合報道，$布魯克 (BRKR.US)$近期主要分析師觀點如下：
發帖Q3報告後，Bruker在中國和生物製藥板塊持續疲軟。
公司在艱難的宏觀經濟環境中遇到了具有挑戰性的收益報告。預估值正在進行調整，以符合降低的2024財政目標；然而，信心仍然存在，公司在多組學和材料科學領域處於戰略位置，這應該從生物製藥需求和中國市場狀況的最終好轉中獲益。
Bruker的第三季度業績未達預期，公司已經調低了2024財年有機銷售增長預期。此次修訂歸因於中國和新興生物製藥板塊的復甦乏力。對指導方針的調整反映出先前可能過於樂觀的預測，而不是在第三季度市場狀況出現顯著下滑。然而，管理層已表達對2025年的信心展望。
提示:
TipRanks為獨立第三方，提供金融分析師的分析數據，並計算分析師推薦的平均回報率和勝率。提供的信息並非投資建議，僅供参考。本文不對評級數據和報告的完整性與準確性做出認可、聲明或保證。
TipRanks提供每位分析師的星級，分析師星級代表分析師所有推薦的過往表現，通過分析師的總勝率和平均回報率综合計算得出，星星越多，則該分析師過往表現越優異，最高爲5颗星。
分析師總勝率為近一年分析師的評級成功次數占總評級次數的比率。評级的成功與否，取決於TipRanks的虚擬投資組合是否從該股票中產生正回報。
總平均回報率為基於分析師的初始評級創建虚擬投資組合，並根據評級變化對組合進行調整，在近一年中該投資組合所獲得的回報率。
